We are live on ! Find out more
MSR

Main Street Research Portfolio holdings

AUM $2.12B
1-Year Est. Return 67.44%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+67.44%
3 Year Est. Return
+232.37%
5 Year Est. Return
+381.46%
10 Year Est. Return
+1,630.85%
AUM
$571M
AUM Growth
+$57.4M
Cap. Flow
+$30.4M
Cap. Flow %
5.33%
Top 10 Hldgs %
28.51%
Holding
118
New
10
Increased
49
Reduced
41
Closed
3

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$30.4M
2
GS icon
Goldman Sachs
GS
+$9.03M
3
HSBC icon
HSBC
HSBC
+$8.51M
4
NTES icon
NetEase
NTES
+$8.43M
5
ROST icon
Ross Stores
ROST
+$1.23M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$11.8M
2
QCOM icon
Qualcomm
QCOM
+$8.66M
3
TTM
Tata Motors Limited
TTM
+$7.58M
4
PG icon
Procter & Gamble
PG
+$5.28M
5
GILD icon
Gilead Sciences
GILD
+$2.29M

Sector Composition

Rank Sector Weight
1 Financials 13.97%
2 Consumer Staples 12.06%
3 Healthcare 10.57%
4 Consumer Discretionary 9.9%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
51
ExxonMobil
XOM
$696B
$3.84M 0.67%
46,857
-338
-0.7% -$28.2K
MCI
52
Barings Corporate Investors
MCI
$393M
$3.77M 0.66%
246,988
-150,230
-38% -$2.28M
IT icon
53
Gartner
IT
$12.4B
$3.19M 0.56%
29,531
-1,535
-5% -$158K
LW icon
54
Lamb Weston
LW
$6.47B
$2.86M 0.5%
68,103
-2,642
-4% -$104K
SCHW
55
Charles Schwab
SCHW
$186B
$2.77M 0.49%
67,900
+202
+0.3% +$8.34K
GILD icon
56
Gilead Sciences
GILD
$181B
$2.07M 0.36%
30,414
-32,624
-52% -$2.29M
BMY icon
57
Bristol-Myers Squibb
BMY
$130B
$1.88M 0.33%
34,653
-200
-0.6% -$11K
ABBV icon
58
AbbVie
ABBV
$465B
$1.68M 0.29%
25,740
+2,080
+9% +$131K
T icon
59
AT&T
T
$183B
$1.6M 0.28%
51,075
-375,140
-88% -$11.8M
CELG
60
DELISTED
Celgene Corp
CELG
$1.52M 0.27%
12,248
-150
-1% -$18K
CLX icon
61
Clorox
CLX
$10.5B
$1.44M 0.25%
10,668
-102
-0.9% -$13.2K
KO icon
62
Coca-Cola
KO
$382B
$1.21M 0.21%
28,610
-2,388
-8% -$99.6K
BIIB icon
63
Biogen
BIIB
$31.9B
$1.13M 0.2%
4,148
-145
-3% -$41K
D icon
64
Dominion Energy
D
$56.2B
$1.12M 0.2%
14,449
+175
+1% +$13.2K
CMCSA icon
65
Comcast
CMCSA
$86.7B
$1.11M 0.19%
29,560
-3,536
-11% -$131K
VTI icon
66
Vanguard Morningstar Total Stock Market ETF
VTI
$681B
$1.09M 0.19%
8,972
– –
CL icon
67
Colgate-Palmolive
CL
$69.4B
$1.08M 0.19%
14,698
-380
-3% -$26.6K
BRK.B icon
68
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.03M 0.18%
6,192
+76
+1% +$12.7K
MRK icon
69
Merck
MRK
$355B
$989K 0.17%
16,313
-502
-3% -$30.5K
GIS icon
70
General Mills
GIS
$19.6B
$899K 0.16%
15,240
-725
-5% -$44.3K
PFE icon
71
Pfizer
PFE
$157B
$848K 0.15%
26,124
-389
-1% -$12.3K
MO icon
72
Altria Group
MO
$117B
$779K 0.14%
10,904
-264
-2% -$19.1K
PM icon
73
Philip Morris
PM
$303B
$719K 0.13%
6,366
-303
-5% -$31.3K
EIX icon
74
Edison International
EIX
$21B
$661K 0.12%
8,305
– –
DIS icon
75
Walt Disney
DIS
$184B
$636K 0.11%
5,607
-39
-0.7% -$4.29K
1 2
3
4 5

Similar funds

PCM
Philosophy Capital Management Alamo, California $2.12B AUM 39.96% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $2.12B AUM 32.36% 1-Year Est. Return
SP
Stairway Partners Chicago, Illinois $2.12B AUM 17.37% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
PSC
Portman Square Capital London, United Kingdom $2.11B AUM 19.71% 1-Year Est. Return
MWA
Midland Wealth Advisors Effingham, Illinois $2.13B AUM 17.72% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Main Street Research's Q1 2017 Portfolio in Review

As of Q1 2017, Main Street Research held 118 positions worth $571M, up 11% from $514M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Main Street Research deployed $30.4M of net new capital in Q1 2017, opening 10 new positions and adding to 49 existing holdings. Its largest new stake was Goldman Sachs: 37,401 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was AT&T, an estimated $11.8M trimmed.

  • Main Street Research's largest Q1 2017 buy was Goldman Sachs: 37,401 shares worth $8.59M.
  • Main Street Research added most to iShares Russell 2000 ETF in Q1 2017, an estimated $30.4M increase.
  • Main Street Research's biggest Q1 2017 reduction was AT&T, cutting an estimated $11.8M.
  • Main Street Research fully exited Qualcomm in Q1 2017, selling an estimated $8.66M.
  • Main Street Research's ten largest holdings make up 29% of its $571M portfolio in Q1 2017.
  • Main Street Research opened 10 new positions and closed 3 in Q1 2017.
  • Main Street Research's portfolio value rose 11% quarter-over-quarter to $571M.

Based on Main Street Research's 13F filing for Q1 2017, filed 4 May 2017.